Olubusi exits Helium Health, signaling broader shift in African tech leadership. Adegoke Olubusi's departure as CEO of Nigerian health-tech firm Helium Health underscores a growing trend of founder transitions as early investors seek liquidity and companies mature beyond their initial startup phase. AU-Startups · Slate Adegoke Olubusi has stepped down as CEO of Nigerian health-tech company Helium Health, marking a significant founder departure that extends a wave of leadership changes across Africa's venture-backed technology sector. Olubusi, who co-founded the company in 2016, leaves after a decade at the helm, with no immediate successor publicly named. His exit reflects a maturing ecosystem where early investors are increasingly pressing for de-risked returns, and founders are confronting the distinct challenges of scaling established organizations versus building nascent ones. Olubusi's departure follows that of co-founder Tito Ovia in 2022, leaving Dimeji Sofowora as the sole remaining co-founder actively involved in the business. While Helium Health has not commented on succession, Sofowora is widely anticipated to assume a larger leadership role. The company has raised over $50 million in venture capital, including a $30 million Series B round in June 2023 led by AXA IM Alts, with participation from Capria Ventures, Angaza Capital, Flatworld Partners, LCY Group, WTI, and AAIC. Existing investors Global Ventures and Tencent also participated in that Series B. This round followed a $10 million Series A in May 2020, co-led by Global Ventures and Africa Healthcare Masterfund (AAIC), with Tencent, Ohara Pharmaceutical Co. Ltd, HOF Capital, Y Combinator, VentureSouq, Chrysalis Capital, Kairos Angels, and Flying Doctors Healthcare Investment Company also participating. The founder exit wave. Olubusi's exit brings the total to at least eight founder-CEO departures in the African tech sector over the past 18 months. This trend includes prominent figures such as Tayo Oviosu at Paga, Katlego Maphai at Yoco, Sim Shagaya at uLesson, Andrew Garza at Lifestores Healthcare, Gregory Rockson at mPharma, Amir Allam at Elmenus, and Daniel Yu at Wasoko. Most of these companies secured their foundational early rounds between 2014 and 2016, coinciding with the initial influx of institutional venture capital into African startups. Now, these ventures are reaching a common inflection point: early investors are seeking de-risked returns, and founders are assessing their capacity and desire to lead larger, more complex organizations. Maphai, upon his departure from Yoco, articulated this sentiment, stating that "the skills and energy needed to start and build a company are not always the same as those required to scale it to the next level." Succession models observed across the continent vary. Some companies, such as OfferZen and Twiga Foods, have brought in external operators, with boards citing the need for enhanced operational rigor at scale. Others, including Paga, uLesson, and Lifestores Healthcare, have opted to promote long-serving internal executives, prioritizing continuity alongside scaling experience. Yoco took a distinct path, appointing a German executive with no prior Africa experience, acknowledging a shortage of local talent combining regional knowledge with institutional scaling expertise. The governance implications of these transitions, particularly when outgoing founders retain board or advisory roles, remain largely untested over a multi-year horizon. What this means for African operators. For founders, this wave of exits signals a shift in investor expectations. The focus is increasingly on proven business models, sustainable revenue, and clear paths to liquidity, rather than speculative early-stage growth. Helium Health, for instance, has an estimated annual revenue of $31.5 million as of 2024 and reached a $94.5 million valuation in 2025 during an M&A offer round. The company's strategy has evolved from solely digitizing hospital records to offering a fintech product, HeliumCredit, which provides digital financing solutions to healthcare facilities. This pivot to embedded finance, leveraging data from its Electronic Medical Records and Hospital Management Information System (EMR/HMIS) solution, HeliumOS, demonstrates a pragmatic approach to revenue generation and market penetration in a capital-intensive sector. However, the path to scale in African health tech is fraught with challenges. Regulatory fragmentation across diverse markets, varying levels of digital literacy, and persistent infrastructure deficits can hinder widespread adoption. While Helium Health has expanded its reach to seven countries across Sub-Saharan Africa and the Middle East, partly through the acquisition of Qatar-based Meddy in 2021, navigating these local conditions effectively requires deep operational expertise. The optimistic case for health tech in Africa rests on the continent's rapidly growing population and increasing demand for improved healthcare services. The skeptical view, however, points to the historical difficulties in monetizing digital health solutions at scale, especially when public health systems are underfunded and private healthcare access is limited. The success of Helium Health's refined strategy, particularly its lending portfolio through HeliumCredit, will depend on its ability to manage credit risk effectively in a sector notorious for payment delays and unpredictable cash flows. Olubusi's next steps involve focusing on health AI research, specifically on how long-horizon healthcare data can be used to build and improve AI systems for medicine across diverse healthcare environments. He also remains a founding managing partner at MAGIC Fund, an early-stage venture fund with over $30 million in assets under management, which has backed more than 250 technology companies. This transition highlights a broader trend where seasoned founders, having built and scaled significant enterprises, are either moving into new ventures, taking on investor roles, or pursuing specialized research, rather than continuing as operational CEOs. For the African tech ecosystem, this means a potential influx of experienced capital and mentorship from founders who have navigated the complexities of building on the continent, even as their companies seek new leadership to drive the next phase of growth and, critically, investor exits. Based on information available at time of publication. Trademarks and logos belong to their respective owners. Spot an error? Write to [email protected]. Editorial policy · Disclaimer.

Learn about the selected grantees of the GSMA Innovation Fund for Humanitarian Challenges and their innovative solutions for humanitarian issues.

Nigerian AI startup Intron Health raises $1.6 million to improve cloud infrastructure.